Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

N Büyükkaramikli; Hedwig Blommestein; R Riemsma; N Armstrong; FJ Clay; J Ross; G Worthy; Hans Severens; J Kleijnen; Maiwenn Al

doi:10.1007/s40273-017-0528-y

Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

N Büyükkaramikli, Hedwig Blommestein, R Riemsma, N Armstrong, FJ Clay, J Ross, G Worthy, Hans Severens, J Kleijnen, Maiwenn Al

Health Technology Assessment (HTA)

Research output: Contribution to journal › Article › Academic › peer-review

17 Citations (Scopus)

6 Downloads (Pure)

Original language	Undefined/Unknown
Journal	Pharmacoeconomics (Print)
DOIs	https://doi.org/10.1007/s40273-017-0528-y
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s40273-017-0528-y

Buyukkaramikli-et-al-2017-.pdfFinal published version, 453 KB

http://hdl.handle.net/1765/105113

Cite this

Büyükkaramikli, N., Blommestein, H., Riemsma, R., Armstrong, N., Clay, FJ., Ross, J., Worthy, G., Severens, H., Kleijnen, J., & Al, M. (2017). Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics (Print). https://doi.org/10.1007/s40273-017-0528-y

@article{8d3415e6655b4d09aad4409503855114,

title = "Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal",

author = "N B{\"u}y{\"u}kkaramikli and Hedwig Blommestein and R Riemsma and N Armstrong and FJ Clay and J Ross and G Worthy and Hans Severens and J Kleijnen and Maiwenn Al",

year = "2017",

doi = "10.1007/s40273-017-0528-y",

language = "Undefined/Unknown",

journal = "PharmacoEconomics",

issn = "1170-7690",

publisher = "Adis",

}

Büyükkaramikli, N, Blommestein, H, Riemsma, R, Armstrong, N, Clay, FJ, Ross, J, Worthy, G, Severens, H, Kleijnen, J & Al, M 2017, 'Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal', Pharmacoeconomics (Print). https://doi.org/10.1007/s40273-017-0528-y

Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. / Büyükkaramikli, N; Blommestein, Hedwig; Riemsma, R et al.
In: Pharmacoeconomics (Print), 2017.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

AU - Büyükkaramikli, N

AU - Blommestein, Hedwig

AU - Riemsma, R

AU - Armstrong, N

AU - Clay, FJ

AU - Ross, J

AU - Worthy, G

AU - Severens, Hans

AU - Kleijnen, J

AU - Al, Maiwenn

PY - 2017

Y1 - 2017

U2 - 10.1007/s40273-017-0528-y

DO - 10.1007/s40273-017-0528-y

M3 - Article

SN - 1170-7690

JO - PharmacoEconomics

JF - PharmacoEconomics

ER -